Stoke Therapeutics Announces MHRA Authorization to Initiate Phase 1/2a Clinical Trial of STK-001 …,

New ADMIRAL study complements ongoing U.S. studies and marks first step in global expansion of clinical development of STK-001 –. – Study will …, New ADMIRAL study complements ongoing U.S. studies and marks first step in global expansion of clinical development of STK-001 –. – Study will …, Read More

Scroll to Top